Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cohera Medical, Inc.® Appoints Paul Thomas to its Board of Directors
- Outerwall (OUTR) Enters $1.6B Merger Agreement (APO)
- Jaguar Animal Health (JAGX) Announces Positive Topline Results of Two Studies to Evaluate Neonorm in Piglets
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!